Study Summary: Concentrated Growth Factor and Sodium Hyaluronate for Temporomandibular Joint Osteoarthritis
Objective
To assess the impact of concentrated growth factor (CGF) combined with sodium hyaluronate (SH) on temporomandibular joint osteoarthritis (TMJOA).
Methods
Sixty TMJOA patients were divided into control and experimental groups. The experimental group received CGF + SH, while the control group received SH only. Pain scores, clinical dysfunction index, and condylar changes were recorded at various intervals.
Results
– The experimental group showed significantly lower pain scores and improved clinical function compared to the control group.
– Condylar bone cortex repair was notably better in the experimental group.
– Three-dimensional reconstruction confirmed the positive CBCT findings.
Conclusion
CGF combined with SH effectively treats TMJOA, reducing muscle and TMJ pain, improving TMJ function, and promoting bone repair.
Practical Solutions and Value
Clinical trials play a crucial role in developing safe treatments. Our AI-driven platform, DocSym, consolidates clinical standards and research, aiding clinicians in everyday practice.
In today’s healthcare landscape, operational efficiency is vital. Our mobile apps support scheduling, treatment monitoring, and telemedicine, streamlining patient care and digital service expansion.
Utilizing AI can enhance clinic workflows and improve patient outcomes, reducing paper routines. Learn more about our solutions at aidevmd.com.
